Abstract
Purpose: In response to the COVID-19 pandemic, extensive operational changes were implemented at our large, tertiary care institution to ensure an appropriate number of intensive care unit beds, personal protective equipment (PPE), testing supplies, ventilators and trained staff. To ease anesthesia and inpatient strain, our institution's policy for hybrid interstitial brachytherapy (ISBT) for cervical cancer (CC) was modified from multiple implants (MI) to a single implant (SI) approach. We aimed to assess the quality of the SI hybrid ISBT approach.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
